Michael E. Lewis, Chief Scientific Advisor at Cara Therapeutics, Inc. (CARA), sold 7,262 shares at $10.60 ($77K) on 2015-02-02, disclosed to the SEC on 2015-02-03.
Scheduled sale ($77k) by Chief Scientific Advisor under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CARA | SELL | 2015-06-02 | $69K | — | Filing → |
| CARA | SELL | 2015-05-05 | $77K | — | Filing → |
| CARA | SELL | 2015-04-02 | $72K | — | Filing → |